Navigation Links
Kosan Opens Registration Program for Lead Hsp90 Inhibitor, Tanespimycin, in Multiple Myeloma
Date:8/19/2007

Tanespimycin is Industry's First Hsp90 Inhibitor to Enter Registration

Program

TIME Registration Program Utilizes New, Proprietary Tanespimycin

Formulation

HAYWARD, Calif., Aug. 2 /PRNewswire-FirstCall/ -- Kosan Biosciences Incorporated (Nasdaq: KOSN) today announced that the TIME-2 trial is open and enrolling patients. This marks the opening of Kosan's Tanespimycin in Myeloma Evaluation or "TIME" registration program for its lead Hsp90 inhibitor, tanespimycin (KOS-953). The TIME program includes two clinical trials: TIME-1 and TIME-2. TIME-1 is a pivotal Phase 3 trial to be conducted in a first-relapse patient population. TIME-2, which is designed to be supportive of the TIME-1 trial, is a Phase 2/3 trial in patients with relapsed-refractory disease. TIME-2 also has the potential to support registration in a relapsed-refractory setting. The TIME program will use Kosan's new, proprietary injectable suspension formulation of tanespimycin. Tanespimycin is the first Hsp90 inhibitor to enter a registration program.

"The opening of our TIME registration program is a major achievement for our company and a milestone in the advancement of Hsp90 inhibition, a promising new approach to cancer therapy," said Robert G. Johnson, Jr., M.D., Ph.D., Kosan's President and Chief Executive Officer. "We continue to be encouraged by the high level of durable responses we observe when tanespimycin combined with bortezomib (Velcade(R)) is administered to patients with relapsed-refractory multiple myeloma, as well as by tanespimycin's manageable safety profile. We believe that a successful outcome in the TIME-2 trial, together with data from our TIME-1
'/>"/>

SOURCE Kosan Biosciences Incorporated

Copyright©2007 PR Newswire.

Page: 1 2 3 4 5 6

Related medicine technology :

1. Kosan Presents Promising Phase 1 Data on Second-Generation Hsp90 Inhibitor, Alvespimycin, Showing Antitumor Activity in Refractory Breast and Ovarian Cancers at ASCO
2. Kosan Presents Phase 1 Data Showing Promising Antitumor Activity and Safety Profile of Epothilone KOS-1584 at ASCO
3. Kosan Presents Data on Lead Hsp90 Inhibitor, Tanespimycin, Showing Promising Antitumor Activity in Multiple Myeloma at ASCO
4. Kosan Presents Preliminary Phase 2 Data Showing Antitumor Activity of Hsp90 Inhibitor Tanespimycin in Metastatic Melanoma at ASCO
5. Kosan Presents Preclinical Data on Nuclear Export Inhibitors, Novel Anticancer Agents, at AACR
6. Kosan Presents Preclinical Antitumor and Safety Data On Next-Generation Epothilone KOS-1803 at AACR
7. Kosan Presents Data on Cardiac Safety Profile of Hsp90 Inhibitor Tanespimycin (KOS-953) at AACR
8. Kosan Announces Data Presentations at Upcoming AACR Annual Meeting
9. Salix Pharmaceuticals Announces Positive Top Line Results of Balsalazide Tablets Registration Study
10. Inspiration Biopharmaceuticals Presents Data From Hemophilia Program at International Society On Thrombosis and Haemostasis (ISTH) Annual Meeting
11. Pieris Progresses Proprietary Asthma Program: Validation of Pulmonary Delivery of Anticalin-Based Protein Product Candidate
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:9/2/2015)... DUBLIN , Sept. 2, 2015 Research ... of the "Inhaled Drug Delivery (London, UK - ... This Inhaled Drug Delivery meeting will cover industry ... and much more. The Co-Chairmen are Dr Steven ... , Senior Director, Mylan. Companies participating ...
(Date:9/2/2015)... Research and Markets ( http://www.researchandmarkets.com/research/6mlrvg/an_introduction ) ... Introduction to Medical Device Software: Regulations and Requirements ... to their offering. This course ... and requirements that apply to Medical Device Software. ... life examples and state-of- the-art practices identified from ...
(Date:9/2/2015)... DUBLIN , Sept. 2, 2015 ... the addition of Jain PharmaBiotech,s new report ... Technologies, Markets and Companies" to their offering. ... cell biology of the BBB have opened new ... the CNS. Several carrier or transport systems, enzymes, ...
Breaking Medicine Technology:An Introduction to Medical Device Software: Regulations and Requirements Course - London, UK - November 2-3, 2015 2Drug Delivery in Central Nervous System Diseases - Technologies, Markets and Companies Report 2015-2024 2Drug Delivery in Central Nervous System Diseases - Technologies, Markets and Companies Report 2015-2024 3
... BOWIE, Md., Dec. 15, 2011  MedAssurant, Inc., ... today announced that Healthcare Partners, IPA (HCPIPA), ... associations (IPA) in the Northeast, has selected ... (CARA™)  solutions to proactively identify gaps in ...
... Mass., Dec. 15, 2011  For parents, knowing how to take ... like sweat or drafts affect the accuracy of results can ... Vicks ® Behind ... out of measuring for fever, restoring confidence to parents and ...
Cached Medicine Technology:Healthcare Partners, IPA, Implements MedAssurant's Innovative, Data-Driven Solutions 2Healthcare Partners, IPA, Implements MedAssurant's Innovative, Data-Driven Solutions 3Behind The Ear -- A New Site To Measure for Fever 2Behind The Ear -- A New Site To Measure for Fever 3
(Date:9/2/2015)... ... 03, 2015 , ... The Aspen Clinic (TAC), located in Basalt, ... kick-starting and inspiring wellness in the Roaring Fork Valley and beyond. , Amanda Wagner, ... mind-body approach to fitness - we are much more than a gym. Our ...
(Date:9/2/2015)... ... September 03, 2015 , ... One can hardly argue against the ... they do laptops and personal computers. These devices are being used as GPS, to ... revolution of mobile dating apps, STD positive singles can now join the prestigious social ...
(Date:9/2/2015)... ... September 03, 2015 , ... Each ... among America’s policymakers, public servants, activists, corporate executives, entrepreneurs, health care professionals, and ... year, that process led the magazine to tap the National League for Nursing’s ...
(Date:9/2/2015)... ... September 02, 2015 , ... Chris Harrison of Harrison’s Footwear of Poulsbo announces ... decision, really,” says Chris. “We have a lot of repeat customers, and many of ... best for them—so we’ve given them the convenience of ordering from home.” , Harrison’s ...
(Date:9/2/2015)... ... September 02, 2015 , ... Healthegy, a leading producer of ... who will deliver keynote presentations at the upcoming Digital Healthcare Innovation Summit ( ... Boston. , Larry Renfro, CEO of Optum, will deliver the morning address. In ...
Breaking Medicine News(10 mins):Health News:TAC Introduces New Retreats for Fall Fitness 2Health News:Herpes-datingsites.com Recently Added Reviews of 5 STD Dating Apps for STD Positive Singles 2Health News:NLN CEO Dr. Beverly Malone Named One of 100 Most Influential in Health Care 2Health News:NLN CEO Dr. Beverly Malone Named One of 100 Most Influential in Health Care 3Health News:Harrison's Comfort Footwear Announces Expansion with New CHarrison Online Store 2Health News:Larry Renfro, CEO of Optum and Jonathan Bush, CEO of AthenaHealth to Address Healthcare Entrepreneurs and Investors at 5th Annual Digital Healthcare Innovation Summit 2Health News:Larry Renfro, CEO of Optum and Jonathan Bush, CEO of AthenaHealth to Address Healthcare Entrepreneurs and Investors at 5th Annual Digital Healthcare Innovation Summit 3
... TODAY, City-wide Rosters to Include Thousands of ... Doctors by Disease Specialty and Location SANTA FE, N.M., ... predictive modeling company, is launching a new quarterly health feature ... The first-of-its-kind online database provides consumers with access to valuable ...
... of her cancer, the first mesothelioma patient treated with a new ... similar to the investigative protocol,s success against several other very aggressive ... ... -- After standard treatments failed to stop or slow the progression ...
... a detailed overview of Watson-Marlow,s High Purity Peristatic Pumps, Tubing and ... ... -- Watson-Marlow, the leading manufacturer of peristaltic solutions, released an informative ... & 2705 at Interphex 2009, from March 17th through March 19th ...
... fight against pediatric neuro-oncologyNEW YORK, May 13 Bonnie ... 7th Annual Dream & Promise Awards Gala, held on ... Times Square to support the Children,s Brain Tumor Foundation, ... with brain and spinal cord tumors and cancer. The ...
... Governor Edward G. Rendell today ... for being the "pioneers" who helped launch his groundbreaking ... and patient-centered medical home initiative. The initiative helps primary ... Pennsylvanians, especially those with chronic diseases, and has the ...
... WASHINGTON, May 13 The following is a statement ... http://www.newscom.com/cgi-bin/prnh/20080918/CFTFKLOGO )Mississippi leaders have ... and taxpayers from the devastating toll of tobacco by ... since 1985. The 50-cent increase, to 68 cents per ...
Cached Medicine News:Health News:Qforma Launches New Database to Help Consumers Find Top Community Medical Experts 2Health News:Qforma Launches New Database to Help Consumers Find Top Community Medical Experts 3Health News:New Cancer Treatment Achieves First Mesothelioma Success 2Health News:Watson-Marlow Releases Informative Video Featuring Showcased High Purity Pumps, Tubing and Fillers at Interphex 2009 2Health News:Watson-Marlow Releases Informative Video Featuring Showcased High Purity Pumps, Tubing and Fillers at Interphex 2009 3Health News:Bonnie Hunt, Melina Kanakaredes and Dr. Ruth Westheimer Lend Their Support to Children's Brain Tumor Foundation Benefit 2Health News:Bonnie Hunt, Melina Kanakaredes and Dr. Ruth Westheimer Lend Their Support to Children's Brain Tumor Foundation Benefit 3Health News:Bonnie Hunt, Melina Kanakaredes and Dr. Ruth Westheimer Lend Their Support to Children's Brain Tumor Foundation Benefit 4Health News:Bonnie Hunt, Melina Kanakaredes and Dr. Ruth Westheimer Lend Their Support to Children's Brain Tumor Foundation Benefit 5Health News:Pennsylvania Governor Rendell Thanks 'Pioneers' for Making Pennsylvania the National Leader on Chronic Care Management and Creating Patient-Centered Medical Homes 2Health News:Pennsylvania Governor Rendell Thanks 'Pioneers' for Making Pennsylvania the National Leader on Chronic Care Management and Creating Patient-Centered Medical Homes 3Health News:Mississippi Tobacco Tax Increase is a Victory for Kids and Taxpayers 2
CRP Liquid Conrtols level 3...
The GLU method used on the Dimension clinical chemistry system is an in vitro diagnostic test intended for the quantitative determination of glucose in serum, plasma, urine and cerebrospinal fluid....
Enzymatic Clearance assay for the in vitro quantitative determination of HDL-cholesterol in human serum and plasma....
For the quantitative in vitro determination of Ammonia in plasma...
Medicine Products: